Jim Simons Homology Medicines, Inc. Transaction History

Renaissance Technologies LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.53 - $1.14 $2,862 - $6,155	-5,400 Reduced 3.0%	174,600 $106,000
Q3 2023 Nov 14, 2023	SELL	$0.84 - $1.43 $100,044 - $170,313	-119,100 Reduced 39.82%	180,000 $211,000
Q2 2023 Aug 11, 2023	SELL	$0.83 - $1.12 $8,397 - $11,331	-10,117 Reduced 3.27%	299,100 $265,000
Q1 2023 May 12, 2023	SELL	$0.91 - $1.69 $21,781 - $40,451	-23,936 Reduced 7.18%	309,217 $318,000
Q4 2022 Feb 13, 2023	SELL	$1.09 - $2.04 $50,082 - $93,731	-45,947 Reduced 12.12%	333,153 $420,000

Q3 2022 Nov 14, 2022	BUY	$1.55 - $3.01 $201,965 - $392,203	130,300 Added 52.37%	379,100 $610,000
Q2 2022 Aug 12, 2022	BUY	$1.39 - $3.12 $20,572 - $46,176	14,800 Added 6.32%	248,800 $490,000
Q1 2022 May 13, 2022	BUY	$2.6 - $4.17 $228,818 - $366,989	88,007 Added 60.28%	234,000 $711,000
Q4 2021 Feb 11, 2022	BUY	$3.64 - $7.78 $531,414 - $1.14 Million	145,993 New	145,993 $531,000
Q3 2020 Nov 13, 2020	SELL	$9.94 - $16.59 $896,588 - $1.5 Million	-90,200 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$12.07 - $19.34 $439,516 - $704,246	36,414 Added 67.7%	90,200 $1.37 Million
Q1 2020 May 14, 2020	BUY	$12.5 - $22.04 $672,325 - $1.19 Million	53,786 New	53,786 $836,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.